Delivery Order SPE2DB22D3011-SPE2DB26FP7HV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL Vial 10mL insulin with a ceiling value of $8,157.52 under a firm fixed-price contract. This non-competitive delivery order was executed on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,696.30 for NovoLog 100 Unit/ML vials (10 mL) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,296.60 for NovoLog 100 Unit/mL vials (10 mL) on August 12, 2025, with completion targeted for August 13, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order valued at $5,186.40 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, supporting the agency's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,372.92 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10 mL) on June 18, 2025, with an ultimate completion date of June 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,761.94 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) on June 16, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain support for military and veteran healthcare...
- The Defense Logistics Agency awarded a $1,749.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside contract represents a routine pharmaceutical procurement issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,765.03 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vial 10mL insulin medication on August 21, 2025, with completion scheduled for August 22, 2025. This competitive award, issued under firm fixed pricing terms, represents a routine pharmaceutical supply transaction supporting military healthcare operations. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,045.96 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/ML vials (10 mL) on October 23, 2025, with an ultimate completion date of October 24, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB26FP7HVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,934.45 to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10mL) with a firm fixed price structure and completion date of October 31, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order fulfillment for insulin pharmaceutical supply to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. The contract performance will occur at the company's corporate office location in Conshohocken, Pennsylvania, and the vendor's extensive federal contract portfolio demonstrates its capability to meet the Defense Logistics Agency's ongoing pharmaceutical distribution requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 10/30/25 |